Q Global Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Q Global Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-132,227	Closed	-$192K	–	111
2024 Q1	$192K	Sell	132,227 -1,000	-0.8%	-$613	0.07%	17
2023 Q4	$13K	Hold	133,227	–	–	0.01%	38
2023 Q3	$20K	Hold	133,227	–	–	0.01%	45
2023 Q2	$12K	Hold	133,227	–	–	0.01%	76
2023 Q1	$7K	Hold	133,227	–	–	﹤0.01%	129
2022 Q4	$6K	Hold	133,227	–	–	﹤0.01%	106
2022 Q3	$5K	Hold	133,227	–	–	﹤0.01%	150
2022 Q2	$20K	Sell	133,227 -105	-0.1%	-$22	0.02%	115
2022 Q1	$40K	Hold	133,332	–	–	0.02%	141
2021 Q4	$68K	Buy	+133,332	New	+$73.7K	0.02%	139

Q Global Advisors's AEON.WS Position: Q2 2024 in Review

Q Global Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 132,227 shares — an estimated $192K sold.

Q Global Advisors first reported a position in AEON.WS in Q4 2021 and held it in 10 quarters. The position peaked at $192K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Q Global Advisors reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Q Global Advisors sold 132,227 AEON Biopharma Inc shares in Q2 2024, an estimated $192K.
Q Global Advisors first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 10 quarters.
Q Global Advisors's AEON Biopharma Inc position peaked at $192K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Q Global Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.